|1.||Maeda, Hiroshi: 9 articles (07/2015 - 03/2002)|
|2.||Greish, Khaled: 6 articles (09/2015 - 01/2005)|
|3.||Zager, Richard A: 5 articles (11/2015 - 01/2008)|
|4.||Fang, Jun: 4 articles (08/2014 - 01/2005)|
|5.||DeVizio, William: 4 articles (04/2011 - 02/2002)|
|6.||Goossens, An: 3 articles (11/2015 - 11/2006)|
|7.||Christophi, Chris: 3 articles (07/2015 - 01/2009)|
|8.||Malcontenti-Wilson, Cathy: 3 articles (07/2015 - 01/2009)|
|9.||Daruwalla, Jurstine: 3 articles (07/2015 - 01/2009)|
|10.||Muralidharan, Vijayaragavan: 3 articles (07/2015 - 01/2009)|
08/01/2013 - "However, in the apical region, maleic acid showed more efficient removal of the smear layer than the other irrigants (P < 0.05)."
01/01/2001 - "The 10% maleic acid totally removed the smear layer, left all the tubules opened and conditioned the intertubular dentin. "
11/01/2009 - "Comparison of the efficacy of maleic acid and ethylenediaminetetraacetic acid in smear layer removal from instrumented human root canal: a scanning electron microscopic study."
11/01/2009 - "The aim of this study was to assess, by scanning electron microscopic (SEM) analysis, the ability of 17% EDTA and 7% maleic acid in the removal of the smear layer from the human root canal system. "
01/01/2012 - "There was no significant difference between smear layer removal of 17% EDTA and 5% maleic acid. "
09/01/2015 - "The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer."
06/01/2012 - "Tumor volume and ADC were monitored by T2-weighted magnetic resonance imaging (MRI) and diffusion-weighted MRI, respectively, in 18 mice with angiogenesis-dependent tumors (U118MG) before (day 0) and after 2, 7, 14, and 21 days of administration of the antiangiogenic agent sunitinib maleate (n = 12) or vehicle (n = 6). "
07/01/2015 - "As a macromolecule (conjugated to styrene-maleic acid [SMA]), SMA-pirarubicin is selective to tumors resulting in improved survival with decreased systemic toxicity. "
01/01/1989 - "Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin."
05/01/1983 - "MT6 tumors with ER grew equally well in males, females, gonadectomized males, males given injections of bromocryptine (1 mg/day) or lisuride hydrogen maleate (50 micrograms/day), and gonadectomized males receiving smaller doses of 17 beta-estradiol (1 to 100 micrograms/2 days). "
12/01/1992 - "A total of 159 adult male and female subjects between 18 and 63 years of age, were entered into a 6-month, double-blind clinical study to assess the effects of a dentifrice containing 0.3% triclosan and 2% of a copolymer of methoxyethylene and maleic acid on supragingival plaque formation and gingivitis, as compared to a placebo dentifrice. "
11/01/1991 - "A total of one hundred twenty-one (121) adult male and female subjects completed a 6-month, double-blind clinical study comparing the effect on supragingival plaque formation and gingivitis of a dentifrice containing 0.3% Triclosan and 2.0% of a copolymer of methoxyethylene and maleic acid to a placebo dentifrice. "
09/01/1990 - "A total of 108 adult male and female subjects completed a 7-month, double-blind clinical study designed to compare the effect of a dentifrice containing 0.3% triclosan and 2% of a copolymer of methoxyethylene and maleic acid on plaque formation and gingivitis, as compared to a placebo dentifrice. "
09/01/1989 - "One hundred eighteen male and female adult subjects were entered into a 14-week, double-blind clinical study to compare the effect of a dentifrice containing 0.3% triclosan and 2% of a copolymer of methoxyethylene and maleic acid on plaque formation and gingivitis. "
02/01/1995 - "A 6-month, single-blind and parallel clinical study was conducted to compare the effects of dentifrice containing 0.3% triclosan and 2.0% of copolymer (methoxyethylene and maleic acid) with a customary oral hygiene procedure on supragingival plaque formation and gingivitis. "
|4.||Fanconi Syndrome (Syndrome, Fanconi)
01/01/2007 - "Maleic Acid is commonly used in research studies to induce Fanconi syndrome in rats and dogs in an attempt to study the mechanism of this disease. "
04/01/2006 - "Detection of maleate-induced Fanconi syndrome by decreasing accumulation of 125I-3-iodo-alpha-methyl-L-tyrosine in the proximal tubule segment-1 region of renal cortex in mice: a trial of separate evaluation of reabsorption."
11/01/1988 - "We conclude, therefore, that SA has a more complex action on the rat renal tubule than sodium maleate, and is likely a much more physiologic model for study of the human renal Fanconi syndrome."
09/01/1983 - "Intestinal amino acid absorption in the Fanconi syndrome: studies in patients and in rats with the maleic acid induced syndrome."
08/01/1978 - "A study has been made of urinary peptide output in rats before and after production of a Fanconi syndrome induced by a single injection of sodium maleate. "
07/01/2006 - "Use of acepromazine (i.e., acetylpromazine) maleate in dogs with a history of seizures is reportedly contraindicated because of the risk of decreasing the seizure threshold in these animals. "
12/01/2005 - "The NMDA receptor antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine maleate (MK-801), administered intraperitoneally 30 or 60 but not 120 min after 4-AP perfusion, when animals show intense electroencephalography epileptiform activity, prevented the delayed neurodegeneration whereas the seizures continued for about 3 h as in the control animals. "
06/30/2009 - "Subeffective doses of 3-ASP plus diazepam, 5S,10R-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) or 6,7-dinitroquinoxaline-2,3-dione (DNQX) increased the latency to the seizure onset induced by PC, suggesting the involvement of ionotropic glutamatergic and GABAergic receptors in anticonvulsant action of 3-ASP. "
07/31/1992 - "Seven days after the last amygdala kindled seizure, [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10- imine maleate ([3H]MK-801) binding, which labels N-methyl-D-aspartate (NMDA)-sensitive receptor-linked cation channels, decreased significantly only in the amygdala of kindled rats compared to that of controls under equilibrium assay conditions. "
08/11/1989 - "In an electrographic model of seizures in the hippocampal slice, both of the N-methyl-D-aspartate (NMDA) antagonists 2-amino-5-phosphonovaleric acid and 5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine maleate (MK-801) prevented the progressive development of seizures but did not block previously induced seizures. "
|4.||Edetic Acid (EDTA)
|6.||3- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)
|7.||methoxyethylene-maleic anhydride copolymer
|8.||Ethyl Ether (Ether)
|9.||Silicon Dioxide (Sand)
|10.||Sodium Fluoride (Ossin)
|3.||Drug Therapy (Chemotherapy)